World Awakening, [12/2/21 3:10 AM]
Scientists refuse to publish supporting research results showing the connection of the Covid vaccine with a sharp increase in heart attacks.

According to one world-renowned cardiologist from the UK, a recently published study, which was presented at a meeting of scientific sessions of the American Heart Association (AHA), states that the risk of developing acute coronary syndrome (ACS), a potentially life-threatening condition that leads to an increased risk of heart disease, increases significantly in patients receiving experimental vaccines against COVID-19 mRNA.
The researchers found that the risk of developing heart disease increases from 11% to 25% in patients receiving Covid-19 vaccines developed by Pfizer and Moderna using new mRNA technology.

The study titled “COVID mRNA vaccines significantly increase endothelial inflammatory markers and risk of ACS according to cardiological test data” was presented by renowned cardiologist Stephen Gundry at the annual AHA Conference on November 8, 2021 and published in the AHA Circulation Medical Journal.
https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712

The study concludes that mRNA vaccines “dramatically increase endothelial inflammation and infiltration of cardiac muscle T-lymphocytes,” which, according to the researchers, probably explains the increase in the number of adverse cardiac or vascular events and side effects such as thrombosis, cardiomyopathy and others in patients after vaccination.

The informant says that the institution decided not to publish the results, but instead chose to hide the results due to fears that it would lose research funding.

Malhotra explained that the informant, who remains anonymous for reasons of his safety, was furious over the decision to bury the results, especially given the fact that the latest health data from the UK show that the number of cardiology-related deaths in the country has increased markedly since the experimental vaccine was provided:

“In good science, we never rely on one study. We need to repeat these conclusions.
A few days ago, after this was published, someone from a very prestigious British institution, a researcher in the Department of cardiology and an informant, contacted me to say that researchers in (his) department had found something similar in the coronary arteries associated with the vaccine.
They had a meeting, and these researchers have decided at the moment that they are not going to publish their findings because they are concerned about the loss of money for research in the pharmaceutical industry.”

Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning

• This article has an expression of concern

  Abstract

  Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS). The score is based on changes from the norm of multiple protein biomarkers including IL-16, a proinflammatory cytokine, soluble Fas, an inducer of apoptosis, and Hepatocyte Growth Factor (HGF)which serves as a marker for chemotaxis of T-cells into epithelium and cardiac tissue, among other markers. Elevation above the norm increases the PULS score, while decreases below the norm lowers the PULS score.The score has been measured every 3-6 months in our patient population for 8 years. Recently, with the advent of the mRNA COVID 19 vaccines (vac) by Moderna and Pfizer, dramatic changes in the PULS score became apparent in most patients.This report summarizes those results. A total of 566 pts, aged 28 to 97, M:F ratio 1:1 seen in a preventive cardiology practice had a new PULS test drawn from 2 to 10 weeks following the 2^nd COVID shot and was compared to the previous PULS score drawn 3 to 5 months previously pre- shot. Baseline IL-16 increased from 35=/-20 above the norm to 82 =/- 75 above the norm post-vac; sFas increased from 22+/- 15 above the norm to 46=/-24 above the norm post-vac; HGF increased from 42+/-12 above the norm to 86+/-31 above the norm post-vac. These changes resulted in an increase of the PULS score from 11% 5 yr ACS risk to 25% 5 yr ACS risk. At the time of this report, these changes persist for at least 2.5 months post second dose of vac.We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.